EnovisvsEli Lilly and Company

ENOV and LLY stock compared: price, dividend, valuation and results, from SEC filings.

ENOV

Enovis Corporation

$26.23

Value $1.5B

-3.21%
ENOV's page

LLY

Eli Lilly and Company

$1,351.12

Value $1.27T

-2.29%
LLY's page

Enovis (ENOV) has a market value of $1.5B and Eli Lilly and Company (LLY) $1.27T. Over the last year, with dividends, ENOV moved -7.1% and LLY +32.0%. Dividend yield: ENOV none, LLY 0.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ENOV$1.5B

    LLY$1.27T

    LLY is 849 times ENOV

  • Revenue, 12 months

    ENOV$2.3B

    LLY$86.5B

    LLY is 37 times ENOV

  • Net income, 12 months

    ENOV-$527M

    LLY$27.6B

  • Operating margin

    ENOV-20.6%

    LLY–

  • ROIC

    ENOV-13.0%

    LLY35.5%

    48.4 points apart

  • P/E

    ENOV–

    LLY46.2

  • Dividend yield

    ENOV0.0%

    LLY0.5%

    0.5 points apart

  • 5-year return

    ENOV-70.1%

    LLY+439.8%

    509.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ENOV-70.1%

LLY+439.8%

020040060020222023202420252026
Returns by period
PeriodENOVWith dividendsLLYWith dividends
1 year since November 18, 2025-7.1%Price -7.1%+32.0%Price +31.2%
3 years since November 17, 2023-48.8%-20.0% a yearPrice -48.8%+132.9%+32.6% a yearPrice +128.3%
5 years since November 18, 2021-70.1%-21.5% a yearPrice -70.1%+439.8%+40.1% a yearPrice +417.0%
10 years since November 21, 2016-58.3%-8.4% a yearPrice -58.3%+1,950.7%+35.3% a yearPrice +1,662.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ENOVEnovisLLYEli Lilly and Company

Valuation

ENOVLLY
Valuation
Price$26.23$1,351.12
Market value$1.5B$1.27T
Enterprise value (EV)$2.7B$1.32T
P/E–46.2
P/E, 5-year median–49.9
P/B1.031.7
EV/EBIT–37.9
Free cash flow yield4.6%1.5%

Results and growth

ENOVLLY
Results and growth
Revenue, 12 months$2.3B$86.5B
Net income, 12 months-$527M$27.6B
Free cash flow, 12 months$70M$19.7B
Earnings per share, 12 months-$9.22$30.81
Revenue growth, year on year6.7%44.7%
Revenue growth a year, past+14.9%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

ENOVLLY
Margins and returns on capital
Gross margin61.3%83.6%
Operating margin-20.6%–
Net margin-22.9%31.9%
ROIC-13.0%35.5%
ROE-33.1%88.6%

Balance sheet

ENOVLLY
Balance sheet
Cash$13M$4.9B
Total debt$1.3B$49.5B
Net debt / EBITDA1.41.2
Interest cover-14.7×38.9×

Dividends and buybacks

ENOVLLY
Dividends and buybacks
Dividend yield–0.5%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield0.2%0.3%
Shareholder yield0.2%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ENOV or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Enovis or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.27T) is about 848.9 times Enovis ($1.5B), at today's prices.

How did ENOV and LLY stock do over the last 10 years?

Since November 21, 2016, ENOV's price moved -58.3% and LLY's +1,662.9%. With dividends: ENOV -58.3% (-8.4% a year), LLY +1,950.7% (+35.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, ENOV or LLY?

The dividend yield at today's price is none for Enovis and 0.47% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

Which has the higher profit margins, Enovis or Eli Lilly and Company?

Over the last twelve months, the net margin was -22.9% for Enovis and 31.9% for Eli Lilly and Company, and the operating margin -20.6% and –. Revenue was $2.3B and $86.5B.

Which is the better investment, Enovis or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.